272 related articles for article (PubMed ID: 32017214)
1. Macrophage activation syndrome in pediatrics.
Alongi A; Naddei R; De Miglio L; Natoli V; Ravelli A
Pediatr Allergy Immunol; 2020 Feb; 31 Suppl 24():13-15. PubMed ID: 32017214
[TBL] [Abstract][Full Text] [Related]
2. The role of interleukin-18 in the diagnosis and monitoring of hemophagocytic lymphohistiocytosis/macrophage activation syndrome - a systematic review.
Krei JM; Møller HJ; Larsen JB
Clin Exp Immunol; 2021 Feb; 203(2):174-182. PubMed ID: 33128796
[TBL] [Abstract][Full Text] [Related]
3. Macrophage activation syndrome associated with griscelli syndrome type 2: case report and review of literature.
Sefsafi Z; Hasbaoui BE; Kili A; Agadr A; Khattab M
Pan Afr Med J; 2018; 29():75. PubMed ID: 29875956
[TBL] [Abstract][Full Text] [Related]
4. Differentiating macrophage activation syndrome in systemic juvenile idiopathic arthritis from other forms of hemophagocytic lymphohistiocytosis.
Lehmberg K; Pink I; Eulenburg C; Beutel K; Maul-Pavicic A; Janka G
J Pediatr; 2013 Jun; 162(6):1245-51. PubMed ID: 23333131
[TBL] [Abstract][Full Text] [Related]
5. Experience with hemophagocytic lymphohistiocytosis/macrophage activation syndrome at a single institution.
Gupta AA; Tyrrell P; Valani R; Benseler S; Abdelhaleem M; Weitzman S
J Pediatr Hematol Oncol; 2009 Feb; 31(2):81-4. PubMed ID: 19194188
[TBL] [Abstract][Full Text] [Related]
6. A Personalized Diagnostic and Treatment Approach for Macrophage Activation Syndrome and Secondary Hemophagocytic Lymphohistiocytosis in Adults.
Kumar B; Aleem S; Saleh H; Petts J; Ballas ZK
J Clin Immunol; 2017 Oct; 37(7):638-643. PubMed ID: 28871523
[TBL] [Abstract][Full Text] [Related]
7. Macrophage activation syndrome in a patient with axial spondyloarthritis on adalimumab.
Baker R; Liew JW; Simonson PD; Soma LA; Starkebaum G
Clin Rheumatol; 2019 Feb; 38(2):603-608. PubMed ID: 30535729
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of refractory hyperferritinemic syndromes with canakinumab: a report of two cases.
Papa R; Natoli V; Caorsi R; Minoia F; Gattorno M; Ravelli A
Pediatr Rheumatol Online J; 2020 Jul; 18(1):56. PubMed ID: 32653009
[TBL] [Abstract][Full Text] [Related]
9. Calm in the midst of cytokine storm: a collaborative approach to the diagnosis and treatment of hemophagocytic lymphohistiocytosis and macrophage activation syndrome.
Halyabar O; Chang MH; Schoettler ML; Schwartz MA; Baris EH; Benson LA; Biggs CM; Gorman M; Lehmann L; Lo MS; Nigrovic PA; Platt CD; Priebe GP; Rowe J; Sundel RP; Surana NK; Weinacht KG; Mann A; Yuen JC; Meleedy-Rey P; Starmer A; Banerjee T; Dedeoglu F; Degar BA; Hazen MM; Henderson LA
Pediatr Rheumatol Online J; 2019 Feb; 17(1):7. PubMed ID: 30764840
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of macrophage activation syndrome and treatment progression.
Dong Y; Wang T; Wu H
Front Immunol; 2024; 15():1389710. PubMed ID: 38736876
[TBL] [Abstract][Full Text] [Related]
11. Elevated serum adenosine deaminase levels in secondary hemophagocytic lymphohistiocytosis.
Chen W; Zhang S; Zhang W; Yang X; Xu J; Qiu H; Zhang X; Li J
Int J Lab Hematol; 2015 Aug; 37(4):544-50. PubMed ID: 25764155
[TBL] [Abstract][Full Text] [Related]
12. Macrophage activation syndrome in autoimmune disease.
Deane S; Selmi C; Teuber SS; Gershwin ME
Int Arch Allergy Immunol; 2010; 153(2):109-20. PubMed ID: 20407267
[TBL] [Abstract][Full Text] [Related]
13. Pathogenesis of macrophage activation syndrome and potential for cytokine- directed therapies.
Schulert GS; Grom AA
Annu Rev Med; 2015; 66():145-59. PubMed ID: 25386930
[TBL] [Abstract][Full Text] [Related]
14. Hemophagocytic lymphohistiocytosis and macrophage activation syndrome: two rare sides of the same devastating coin.
Sztajnbok F; Fonseca AR; Campos LR; Lino K; Rodrigues MCF; Silva RM; de Almeida RG; Perazzio SF; Carvalho MFF
Adv Rheumatol; 2024 Apr; 64(1):28. PubMed ID: 38627860
[TBL] [Abstract][Full Text] [Related]
15. Cytokines in systemic juvenile idiopathic arthritis and haemophagocytic lymphohistiocytosis: tipping the balance between interleukin-18 and interferon-γ.
Put K; Avau A; Brisse E; Mitera T; Put S; Proost P; Bader-Meunier B; Westhovens R; Van den Eynde BJ; Orabona C; Fallarino F; De Somer L; Tousseyn T; Quartier P; Wouters C; Matthys P
Rheumatology (Oxford); 2015 Aug; 54(8):1507-17. PubMed ID: 25767156
[TBL] [Abstract][Full Text] [Related]
16. Case Report: Systemic Inflammatory Response and Fast Recovery in a Pediatric Patient With COVID-19.
Klocperk A; Parackova Z; Dissou J; Malcova H; Pavlicek P; Vymazal T; Dolezalova P; Sediva A
Front Immunol; 2020; 11():1665. PubMed ID: 32719688
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Moderately Dosed Etoposide in Macrophage Activation Syndrome-Hemophagocytic Lymphohistiocytosis.
Horne A; von Bahr Greenwood T; Chiang SCC; Meeths M; Björklund C; Ekelund M; Erensjö P; Berg S; Hagelberg S; Bryceson YT; Andersson U; Henter JI
J Rheumatol; 2021 Oct; 48(10):1596-1602. PubMed ID: 33589555
[TBL] [Abstract][Full Text] [Related]
18. The 2022 EULAR/ACR points to consider at the early stages of diagnosis and management of suspected haemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS).
Shakoory B; Geerlinks A; Wilejto M; Kernan K; Hines M; Romano M; Piskin D; Ravelli A; Sinha R; Aletaha D; Allen C; Bassiri H; Behrens EM; Carcillo J; Carl L; Chatham W; Cohen JI; Cron RQ; Drewniak E; Grom AA; Henderson LA; Horne A; Jordan MB; Nichols KE; Schulert G; Vastert S; Demirkaya E; Goldbach-Mansky R; de Benedetti F; Marsh RA; Canna SW;
Ann Rheum Dis; 2023 Oct; 82(10):1271-1285. PubMed ID: 37487610
[TBL] [Abstract][Full Text] [Related]
19. Development and Initial Validation of the Macrophage Activation Syndrome/Primary Hemophagocytic Lymphohistiocytosis Score, a Diagnostic Tool that Differentiates Primary Hemophagocytic Lymphohistiocytosis from Macrophage Activation Syndrome.
Minoia F; Bovis F; Davì S; Insalaco A; Lehmberg K; Shenoi S; Weitzman S; Espada G; Gao YJ; Anton J; Kitoh T; Kasapcopur O; Sanner H; Merino R; Astigarraga I; Alessio M; Jeng M; Chasnyk V; Nichols KE; Huasong Z; Li C; Micalizzi C; Ruperto N; Martini A; Cron RQ; Ravelli A; Horne A;
J Pediatr; 2017 Oct; 189():72-78.e3. PubMed ID: 28807357
[TBL] [Abstract][Full Text] [Related]
20. Macrophage activation syndrome and cytokine-directed therapies.
Schulert GS; Grom AA
Best Pract Res Clin Rheumatol; 2014 Apr; 28(2):277-92. PubMed ID: 24974063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
